Iram Zafar

1.7k total citations
28 papers, 1.4k citations indexed

About

Iram Zafar is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Iram Zafar has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Iram Zafar's work include Genetic and Kidney Cyst Diseases (11 papers), Renal and related cancers (6 papers) and Biomedical Research and Pathophysiology (5 papers). Iram Zafar is often cited by papers focused on Genetic and Kidney Cyst Diseases (11 papers), Renal and related cancers (6 papers) and Biomedical Research and Pathophysiology (5 papers). Iram Zafar collaborates with scholars based in United States, Norway and France. Iram Zafar's co-authors include Charles L. Edelstein, Rafeul Alam, James T. Good, Donald Rollins, Richard J. Martin, Franck A. Belibi, Christina A. Christianson, Kameswaran Ravichandran, Magdalena Górska‐Ponikowska and Magdalena M. Gorska and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of the New York Academy of Sciences and Kidney International.

In The Last Decade

Iram Zafar

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iram Zafar United States 18 483 482 434 407 259 28 1.4k
Catherine Hall United States 13 207 0.4× 291 0.6× 308 0.7× 68 0.2× 279 1.1× 19 1.6k
George Moxley United States 20 661 1.4× 151 0.3× 270 0.6× 91 0.2× 80 0.3× 37 1.5k
Asahi Hishida Japan 23 184 0.4× 166 0.3× 574 1.3× 114 0.3× 326 1.3× 89 1.5k
Christine Kurschat Germany 20 121 0.3× 355 0.7× 460 1.1× 98 0.2× 110 0.4× 78 1.2k
Artur Bossowski Poland 23 665 1.4× 215 0.4× 298 0.7× 719 1.8× 429 1.7× 168 2.2k
Heike Goebel Germany 14 377 0.8× 236 0.5× 184 0.4× 65 0.2× 171 0.7× 29 1.0k
Cong-Lin Liu United States 15 226 0.5× 201 0.4× 247 0.6× 156 0.4× 160 0.6× 21 913
Martin A. Turman United States 18 126 0.3× 62 0.1× 418 1.0× 263 0.6× 396 1.5× 47 1.1k
Yang Jia China 16 280 0.6× 160 0.3× 200 0.5× 42 0.1× 156 0.6× 39 1.1k
G. Del Toro United States 13 344 0.7× 99 0.2× 481 1.1× 58 0.1× 136 0.5× 25 1.6k

Countries citing papers authored by Iram Zafar

Since Specialization
Citations

This map shows the geographic impact of Iram Zafar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iram Zafar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iram Zafar more than expected).

Fields of papers citing papers by Iram Zafar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iram Zafar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iram Zafar. The network helps show where Iram Zafar may publish in the future.

Co-authorship network of co-authors of Iram Zafar

This figure shows the co-authorship network connecting the top 25 collaborators of Iram Zafar. A scholar is included among the top collaborators of Iram Zafar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iram Zafar. Iram Zafar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zafar, Iram, William E. Louch, Ganesh V. Halade, et al.. (2024). Myocardial SERCA2 Protects Against Cardiac Damage and Dysfunction Caused by Inhaled Bromine. Journal of Pharmacology and Experimental Therapeutics. 390(1). 146–158. 1 indexed citations
2.
Mariappan, Nithya, Iram Zafar, Annette Robichaud, et al.. (2023). Pulmonary pathogenesis in a murine model of inhaled arsenical exposure. Archives of Toxicology. 97(7). 1847–1858. 4 indexed citations
3.
Zafar, Iram, Nithya Mariappan, Shama Ahmad, et al.. (2023). A Murine Model of Vesicant-Induced Acute Lung Injury. Journal of Pharmacology and Experimental Therapeutics. 388(2). 568–575. 4 indexed citations
4.
Ahmad, Shama, et al.. (2021). Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19. Seminars in Cancer Biology. 83. 384–398. 59 indexed citations
5.
Mariappan, Nithya, Iram Zafar, Chih‐Chang Wei, et al.. (2020). Cutaneous lewisite exposure causes acute lung injury. Annals of the New York Academy of Sciences. 1479(1). 210–222. 24 indexed citations
6.
Mariappan, Nithya, Maroof Husain, Iram Zafar, et al.. (2020). Extracellular nucleic acid scavenging rescues rats from sulfur mustard analog-induced lung injury and mortality. Archives of Toxicology. 94(4). 1321–1334. 18 indexed citations
7.
Bradley, Wayne E., Chih‐Chang Wei, Iram Zafar, et al.. (2020). Chronic cardiac structural damage, diastolic and systolic dysfunction following acute myocardial injury due to bromine exposure in rats. Archives of Toxicology. 95(1). 179–193. 4 indexed citations
8.
Liu, Weimin, Sucai Liu, Mukesh Verma, et al.. (2016). Mechanism of TH2/TH17-predominant and neutrophilic TH2/TH17-low subtypes of asthma. Journal of Allergy and Clinical Immunology. 139(5). 1548–1558.e4. 110 indexed citations
9.
Christianson, Christina A., N. Goplen, Iram Zafar, et al.. (2015). Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. Journal of Allergy and Clinical Immunology. 136(1). 59–68.e14. 243 indexed citations
10.
Ravichandran, Kameswaran, Iram Zafar, Zhibin He, et al.. (2014). An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2. Human Molecular Genetics. 23(18). 4919–4931. 36 indexed citations
11.
Ravichandran, Kodi S., et al.. (2014). An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease. Nephrology Dialysis Transplantation. 30(1). 45–53. 35 indexed citations
12.
Zafar, Iram, James T. Good, Donald Rollins, et al.. (2014). Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma. Journal of Allergy and Clinical Immunology. 134(5). 1175–1186.e7. 250 indexed citations
13.
Klawitter, Jelena, Iram Zafar, Jost Klawitter, et al.. (2013). Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease. BMC Nephrology. 14(1). 165–165. 17 indexed citations
14.
Belibi, Franck A., Iram Zafar, Kameswaran Ravichandran, et al.. (2011). Hypoxia-inducible factor-1α (HIF-1α) and autophagy in polycystic kidney disease (PKD). American Journal of Physiology-Renal Physiology. 300(5). F1235–F1243. 97 indexed citations
15.
Doctor, R. Brian, Natalie J. Serkova, Kendra M. Hasebroock, Iram Zafar, & Charles L. Edelstein. (2010). Distinct patterns of kidney and liver cyst growth in pkd2(WS25/−) mice. Nephrology Dialysis Transplantation. 25(11). 3496–3504. 11 indexed citations
16.
Zafar, Iram, Kameswaran Ravichandran, Franck A. Belibi, R. Brian Doctor, & Charles L. Edelstein. (2010). Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease. Kidney International. 78(8). 754–761. 85 indexed citations
17.
Zafar, Iram, Franck A. Belibi, Zhibin He, & Charles L. Edelstein. (2009). Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD). Nephrology Dialysis Transplantation. 24(8). 2349–2353. 67 indexed citations
18.
Tao, Yunxia, Iram Zafar, Jun Kim, Robert W. Schrier, & Charles L. Edelstein. (2008). Caspase-3 Gene Deletion Prolongs Survival in Polycystic Kidney Disease. Journal of the American Society of Nephrology. 19(4). 749–755. 34 indexed citations
19.
Tao, Yunxia, Yajie Yin, Iram Zafar, et al.. (2007). VEGF receptor inhibition slows the progression of polycystic kidney disease. Kidney International. 72(11). 1358–1366. 50 indexed citations
20.
Zafar, Iram, Yunxia Tao, Sandor Falk, et al.. (2007). Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model. American Journal of Physiology-Renal Physiology. 293(3). F854–F859. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Hall Breakdown of academic impact, for papers by George Moxley Breakdown of academic impact, for papers by Asahi Hishida Breakdown of academic impact, for papers by Christine Kurschat Breakdown of academic impact, for papers by Artur Bossowski Breakdown of academic impact, for papers by Heike Goebel Breakdown of academic impact, for papers by Cong-Lin Liu Breakdown of academic impact, for papers by Martin A. Turman Breakdown of academic impact, for papers by Yang Jia Breakdown of academic impact, for papers by G. Del Toro
Rankless by CCL
2026